Skip to main contentSkip to navigation
Sirius Investors

Humanoid Inc (HERB) Financial Metrics

This dashboard provides comprehensive financial metrics and analysis to help evaluate Humanoid Inc's investment potential. View key valuation ratios, profitability metrics, growth indicators, and historical trends to make informed investment decisions.

Financial Metrics Score

Valuation Metrics

Sector benchmarks: Industrials

2024
P/E Ratio
1.72
Strong
WeakModerateStrong
P/B Ratio
0.05
Strong
WeakModerateStrong
Earnings Yield
58.34%
Strong
WeakModerateStrong

Profitability Health

2024
Return on Equity
2.84%
Weak
WeakModerateStrong
Operating Margin
29.81%
Strong
WeakModerateStrong
Net Profit Margin
33.42%
Strong
WeakModerateStrong

Growth Indicators

2024
Revenue Growth
14.25%
Strong
WeakModerateStrong
Net Income Growth
15.00%
Moderate
WeakModerateStrong
EPS Growth
15.02%
Strong
WeakModerateStrong

Efficiency & Liquidity

2024
Current Ratio
3.24
Strong
WeakModerateStrong
Quick Ratio
2.55
Strong
WeakModerateStrong
Asset Turnover
0.08x
Weak
WeakModerateStrong
Inventory Turnover
5.49x
Moderate
WeakModerateStrong

Cash Flow & Resilience

Core fortress metrics for cash-rich balance sheets in high-inflation / tech-volatility regimes

2024
Free Cash Flow Yield
19.80%
Strong
WeakModerateStrong
EV / Free Cash Flow
2.02x
Strong
WeakModerateStrong
Net Debt / EBITDA
-1.08x
Strong
WeakModerateStrong
Interest Burden (EBT / EBIT)
1.121
Strong
WeakModerateStrong
Return on Invested Capital
2.52%
Weak
WeakModerateStrong
Cash Conversion Cycle
73.84 days
Weak
WeakModerateStrong

Fortress screener guardrails

2/4 passing
  • FCF Yield > 3%
  • Net Debt / EBITDA < 1.5x
  • ROIC > 20%
  • Cash Conversion Cycle < 0 days

Financial Statements

Want to see the complete financial picture? View detailed financial statements including income statements, balance sheets, and cash flow statements for HERB.

View Financial Statements